Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, according to a study published in Advanced Science. Inside cells, DNA mixes ...

Get Instant Summarized Text (Gist) A novel antibody therapy using IgE, rather than the conventional IgG, shows potential in treating ovarian cancer by reactivating immune cells. The IgE antibody ...

New research has revealed how a novel IgE antibody (MOv18) therapy reactivates the immune cells of ovarian cancer patients, enabling them to fight the disease more effectively. Conducted by ...

Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for ...

The team investigated an IgE antibody called MOv18, exploring its ability to activate immune cells from patients at Guy’s and St Thomas’ NHS Foundation Trust with ovarian cancer and its influence on ...

but also the cancer stem cells, one can eradicate the CSCs that would repopulate the tumor," Herzog said. The 81 patients with platinum-resistant ovarian cancer (cancer recurrence within six ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.